Iodure De Potassium Serb (Potassium Iodide)

Potassium iodide delivers a large amount of stable iodide that is quickly absorbed and saturates the thyroid gland. This saturation triggers the Wolff‑Chaikoff effect, temporarily shutting down iodine organification and thyroid hormone synthesis, which blocks the gland from taking up any radioactive iodine that may be present.

The appropriate dose of Iodure De Potassium Serb is determined by a qualified prescriber based on the specific indication, patient age, weight, and clinical circumstances. Healthcare professionals set the regimen according to national guidelines and individual risk assessment.

Safety data for potassium iodide in pregnancy and lactation are limited. The product should only be used when the potential benefit outweighs any possible risk, and the decision must be made by a healthcare professional after evaluating the mother’s iodine status and clinical need.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Iodure De Potassium Serb provides potassium iodide, a stable inorganic iodine source commonly used for rapid thyroid blocking. Compared with liquid Lugol’s iodine, potassium iodide tablets are easier to store, have a longer shelf‑life, and deliver a precise iodide dose without the need for dilution.

The product should be stored at ambient temperature, below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight and sources of heat. Ensure the container is tightly closed to maintain stability and potency.

Iodure De Potassium Serb is taken orally. The tablet (or oral preparation) is swallowed with water as directed by the prescribing clinician. Administration should follow the timing recommendations for the specific indication, such as before or shortly after potential radioactive iodine exposure.

Serious risks include severe allergic reactions such as anaphylaxis, significant thyroid dysfunction (both hypo‑ and hyperthyroidism), and rare cases of acute pulmonary edema. Patients should be monitored for signs of these reactions, especially if they have a history of thyroid disease or iodine hypersensitivity.

Individuals with a known allergy to iodine or iodide, those with certain thyroid disorders (e.g., untreated hyperthyroidism) without medical supervision, and patients with severe renal impairment should avoid using the product unless a healthcare professional determines it is safe.